Per Christian Sontum
Nessuna posizione attualmente
Patrimonio netto: 1 M $ in data 30/06/2024
Provenienza dei contatti di primo grado di Per Christian Sontum
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 9 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Per Christian Sontum tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| GE AEROSPACE | Industrial Machinery | Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| EQUINOR ASA | Integrated Oil | General Counsel | |
| American Pharmaceutical Group | Chairman | ||
| AQUA BIO TECHNOLOGY ASA | Chemicals: Major Diversified | Director/Board Member | |
| MALIN CORPORATION PLC | Biotechnology | Director/Board Member | |
| University of Oxford | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Glasgow | College/University | Undergraduate Degree | |
Synexus Compass, Inc.
 Synexus Compass, Inc. Medical/Nursing ServicesHealth Services Synexus Compass, Inc. provided medical image-analysis, subject-recruitment and biochemical marker services that enable life-science industry clients to execute clinical trials while decreasing the time, uncertainty and cost of product development. The company was founded in 1998 and was headquartered in San Francisco, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
Arsenal Capital Management LP
 Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital Management LP (Arsenal Capital) is a private equity subsidiary of Arsenal Capital Group LLC founded in 2000 by Terrence M. Mullen and Jeffrey B. Kovach. The firm is headquartered in New York. | Investment Managers | Director/Board Member | |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Medical Specialties | President Sales & Marketing Corporate Officer/Principal | |
IoDP Medical Imaging Research
 IoDP Medical Imaging Research Miscellaneous Commercial ServicesCommercial Services Part of Thermo Fisher Scientific, Inc., IoDP Medical Imaging Research provides customized services for medical image analysis and image management in clinical trials to pharmaceutical and biotech companies, CROs, and public research organizations. The company is based in Sevres, France. IoDP Medical Imaging Research was acquired by Synexus Compass, Inc., part of Thermo Fisher Scientific, Inc. from September 03, 2019 on July 27, 2004. | Miscellaneous Commercial Services | Chief Executive Officer | |
| University of London | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| The Open University | College/University | Graduate Degree | |
| ARCTICZYMES TECHNOLOGIES ASA | Medical Specialties | Director/Board Member | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Norwegian University of Science & Technology | College/University | Doctorate Degree | |
| University of Bergen | College/University | Corporate Officer/Principal | |
| University of Paris Jussieu | College/University | Undergraduate Degree | |
| NAVAMEDIC ASA | Medical Distributors | Director/Board Member | |
Center For Clinical & Basic Research
 Center For Clinical & Basic Research Miscellaneous Commercial ServicesCommercial Services Part of Thermo Fisher Scientific, Inc., Center For Clinical & Basic Research is a Danish company that provides radiology services. The company is based in Ballerup, Denmark. The company was founded by Claus Henrik Christiansen. Center For Clinical & Basic Research was acquired by Synexus Compass, Inc., part of Thermo Fisher Scientific, Inc. from September 03, 2019 on July 14, 2006. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Amersham Health | Sales & Marketing | ||
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
| King's College London | College/University | Doctorate Degree | |
The Association of the British Pharmaceutical Industry
 The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| DIUL GROUP | Pharmaceuticals: Major | Director/Board Member | |
| SCANCELL HOLDINGS PLC | Biotechnology | Chairman | |
Wipro GE HealthCare Pvt Ltd.
 Wipro GE HealthCare Pvt Ltd. Information Technology ServicesTechnology Services Wipro GE Healthcare Pvt Ltd. is an information technology company that designs and develops medical equipment. The company was founded on March 14, 1990 and is headquartered in Bangalore, India. | Information Technology Services | Director/Board Member | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| PAACS Invest AS | Chairman | ||
| LANTHEUS HOLDINGS, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
WIRB- Copernicus Group, Inc.
 WIRB- Copernicus Group, Inc. Miscellaneous Commercial ServicesCommercial Services WIRB- Copernicus Group, Inc. engages in the provision solutions for clinical research. The firm offers study planning and site optimization, patient engagement, scientific and regulatory, market insights, and ethical and biosafety review services. The company was founded in 2012 and is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
| SOPHIA GENETICS SA | Packaged Software | Director/Board Member | |
Altor Fund Manager AB
 Altor Fund Manager AB Investment ManagersFinance Part of Altor Equity Partners AB, Altor Fund Manager AB is a company founded in 2014. The company is based in Stockholm, Sweden. The Swedish company's description states that they are a "hytte" for everyone, entrepreneurs at heart, engaged in partnerships built on curiosity, creativity, and achieving a lasting impact. | Investment Managers | Chairman | |
Malin Life Sciences Holdings Ltd.
 Malin Life Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Malin Corp. Plc, Malin Life Sciences Holdings Ltd. functions as an investment holding Irish company. The company is based in Dublin, Ireland. The CEO of the company is George Kelly Martin. | Financial Conglomerates | Director/Board Member | |
Fortuna Fix, Inc.
 Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Biotechnology | Founder | |
Centre For Probe Development & Commercialization
 Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | Pharmaceuticals: Major | Director/Board Member | |
Pharmasum Therapeutics AS
 Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Biotechnology | Director/Board Member | |
EraCal Therapeutics AG
 EraCal Therapeutics AG Miscellaneous Commercial ServicesCommercial Services EraCal Therapeutics AG operates as a preclinical biotech company. The firm engages in researching and developing biotechnology. The company was founded by Joshua Jordi in September 2018 and is headquartered in Zollikon, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member | |
| Universite Paris Cite | College/University | Doctorate Degree | |
| Theranostics Consulting SAS | Corporate Officer/Principal | ||
| SMO-CLINICA SAS | Founder | ||
| Université Paris-Saclay | College/University | Doctorate Degree | |
Hemispherian AS
 Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | Miscellaneous Commercial Services | Director/Board Member | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member | |
Complement Therapeutics Ltd.
 Complement Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Complement Therapeutics Ltd. develops medicines that target the complement system. The British company was founded by Richard Unwin, Simon J. Clark, and Paul Bishop. The CEO is Rafiq Hasan. | Pharmaceuticals: Major | Chief Executive Officer | |
| University Pierre & Marie Curie | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 17 |
| Norvegia | 10 |
| Stati Uniti | 9 |
| Francia | 8 |
| Canada | 4 |
Settori
| Health Technology | 18 |
| Consumer Services | 12 |
| Commercial Services | 8 |
| Finance | 4 |
| Technology Services | 3 |
Posizioni
| Director/Board Member | 48 |
| Corporate Officer/Principal | 11 |
| Chairman | 9 |
| Undergraduate Degree | 8 |
| Doctorate Degree | 7 |
Contatti più connessi
- Borsa valori
- Insiders
- Per Christian Sontum
- Connessioni Società
